A systematic review of drug-induced subacute cutaneous lupus erythematosus.
Lowe
G C
GC
University of Utah School of Medicine, Salt Lake City, USA.
Lowe
G
G
Henderson
C L
CL
Grau
R H
RH
Hansen
C B
CB
Sontheimer
R D
RD
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000935:Antifungal Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D000970:Antineoplastic Agents / Q000009:adverse effects; D001688:Biological Products / Q000009:adverse effects; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006633:Histamine Antagonists / Q000009:adverse effects; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects; D008178:Lupus Erythematosus, Cutaneous / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology; D008297:Male; D008875:Middle Aged; D054328:Proton Pump Inhibitors / Q000009:adverse effects; D014467:Ultraviolet Therapy / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000927:Anticonvulsants; D000935:Antifungal Agents; D000959:Antihypertensive Agents; D000970:Antineoplastic Agents; D001688:Biological Products; D006633:Histamine Antagonists; D007155:Immunologic Factors; D054328:Proton Pump Inhibitors